These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 19428897)

  • 1. Immunogenicity and protection-inducing ability of recombinant Plasmodium vivax rhoptry-associated protein 2 in Aotus monkeys: a potential vaccine candidate.
    Rojas-Caraballo J; Mongui A; Giraldo MA; Delgado G; Granados D; Millan-Cortes D; Martinez P; Rodriguez R; Patarroyo MA
    Vaccine; 2009 May; 27(21):2870-6. PubMed ID: 19428897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccination with recombinant Plasmodium vivax MSP-10 formulated in different adjuvants induces strong immunogenicity but no protection.
    Giraldo MA; Arevalo-Pinzon G; Rojas-Caraballo J; Mongui A; Rodriguez R; Patarroyo MA
    Vaccine; 2009 Dec; 28(1):7-13. PubMed ID: 19782110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective efficacy of a Plasmodium vivax circumsporozoite protein-based vaccine in Aotus nancymaae is associated with antibodies to the repeat region.
    Yadava A; Hall CE; Sullivan JS; Nace D; Williams T; Collins WE; Ockenhouse CF; Barnwell JW
    PLoS Negl Trop Dis; 2014 Oct; 8(10):e3268. PubMed ID: 25329054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity and protective efficacy of recombinant vaccine based on the receptor-binding domain of the Plasmodium vivax Duffy binding protein in Aotus monkeys.
    Arévalo-Herrera M; Castellanos A; Yazdani SS; Shakri AR; Chitnis CE; Dominik R; Herrera S
    Am J Trop Med Hyg; 2005 Nov; 73(5 Suppl):25-31. PubMed ID: 16291763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmodium vivax thrombospondin related adhesion protein: immunogenicity and protective efficacy in rodents and Aotus monkeys.
    Castellanos A; Arévalo-Herrera M; Restrepo N; Gulloso L; Corradin G; Herrera S
    Mem Inst Oswaldo Cruz; 2007 Jun; 102(3):411-6. PubMed ID: 17568948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of recombinant PvDBPII, receptor binding domain of Plasmodium vivax Duffy binding protein, and evaluation of immunogenicity to identify an adjuvant formulation for vaccine development.
    Bhardwaj R; Shakri AR; Hans D; Gupta P; Fernandez-Becerra C; Del Portillo HA; Pandey G; Chitnis CE
    Protein Expr Purif; 2017 Aug; 136():52-57. PubMed ID: 26578115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the immune responses induced by soluble and particulate Plasmodium vivax circumsporozoite vaccine candidates formulated in AS01 in rhesus macaques.
    Vanloubbeeck Y; Pichyangkul S; Bayat B; Yongvanitchit K; Bennett JW; Sattabongkot J; Schaecher K; Ockenhouse CF; Cohen J; Yadava A;
    Vaccine; 2013 Dec; 31(52):6216-24. PubMed ID: 24144477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antigenicity of a Plasmodium vivax reticulocyte binding protein-1 (PvRBP1) recombinant fragment in humans and its immunogenicity and protection studies in Aotus monkeys.
    Rojas Caraballo J; Delgado G; Rodriguez R; Patarroyo MA
    Vaccine; 2007 May; 25(18):3713-21. PubMed ID: 17240494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global genetic diversity of the Plasmodium vivax transmission-blocking vaccine candidate Pvs48/45.
    Vallejo AF; Martinez NL; Tobon A; Alger J; Lacerda MV; Kajava AV; Arévalo-Herrera M; Herrera S
    Malar J; 2016 Apr; 15():202. PubMed ID: 27067024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and antigenicity of the promising vaccine candidate Plasmodium vivax 34kDa rhoptry antigen (Pv34).
    Mongui A; Angel DI; Gallego G; Reyes C; Martinez P; Guhl F; Patarroyo MA
    Vaccine; 2009 Dec; 28(2):415-21. PubMed ID: 19837093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigenicity and immunogenicity of a novel chimeric peptide antigen based on the P. vivax circumsporozoite protein.
    Céspedes N; Arévalo-Herrera M; Felger I; Reed S; Kajava AV; Corradin G; Herrera S
    Vaccine; 2013 Oct; 31(42):4923-30. PubMed ID: 23954378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification, characterization and antigenicity of the Plasmodium vivax rhoptry neck protein 1 (PvRON1).
    Moreno-Perez DA; Montenegro M; Patarroyo ME; Patarroyo MA
    Malar J; 2011 Oct; 10():314. PubMed ID: 22024312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant Pvs48/45 antigen expressed in E. coli generates antibodies that block malaria transmission in Anopheles albimanus mosquitoes.
    Arévalo-Herrera M; Vallejo AF; Rubiano K; Solarte Y; Marin C; Castellanos A; Céspedes N; Herrera S
    PLoS One; 2015; 10(3):e0119335. PubMed ID: 25775466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigenicity and immunogenicity of PvRALP1, a novel Plasmodium vivax rhoptry neck protein.
    Cheng Y; Li J; Ito D; Kong DH; Ha KS; Lu F; Wang B; Sattabongkot J; Lim CS; Tsuboi T; Han ET
    Malar J; 2015 Apr; 14():186. PubMed ID: 25925592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of long synthetic peptides to study the antigenicity and immunogenicity of the Plasmodium vivax circumsporozoite protein.
    Herrera S; Bonelo A; Perlaza BL; Valencia AZ; Cifuentes C; Hurtado S; Quintero G; López JA; Corradin G; Arévalo-Herrera M
    Int J Parasitol; 2004 Dec; 34(13-14):1535-46. PubMed ID: 15582530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune responses and protection of Aotus monkeys immunized with irradiated Plasmodium vivax sporozoites.
    Jordán-Villegas A; Perdomo AB; Epstein JE; López J; Castellanos A; Manzano MR; Hernández MA; Soto L; Méndez F; Richie TL; Hoffman SL; Arévalo-Herrera M; Herrera S
    Am J Trop Med Hyg; 2011 Feb; 84(2 Suppl):43-50. PubMed ID: 21292877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic oligodeoxynucleotides containing CpG motifs enhance immunogenicity of a peptide malaria vaccine in Aotus monkeys.
    Jones TR; Obaldia N; Gramzinski RA; Charoenvit Y; Kolodny N; Kitov S; Davis HL; Krieg AM; Hoffman SL
    Vaccine; 1999 Aug; 17(23-24):3065-71. PubMed ID: 10462241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A recombinant vaccine based on domain II of Plasmodium vivax Apical Membrane Antigen 1 induces high antibody titres in mice.
    Gentil F; Bargieri DY; Leite JA; Françoso KS; Patricio MB; Espíndola NM; Vaz AJ; Palatnik-de-Sousa CB; Rodrigues MM; Costa FT; Soares IS
    Vaccine; 2010 Aug; 28(38):6183-90. PubMed ID: 20654667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity of Plasmodium vivax combination subunit vaccine formulated with human compatible adjuvants in mice.
    Devi YS; Mukherjee P; Yazdani SS; Shakri AR; Mazumdar S; Pandey S; Chitnis CE; Chauhan VS
    Vaccine; 2007 Jul; 25(28):5166-74. PubMed ID: 17544179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of immune responses elicited in mice against a recombinant malaria vaccine based on Plasmodium vivax Duffy binding protein.
    Yazdani SS; Shakri AR; Mukherjee P; Baniwal SK; Chitnis CE
    Vaccine; 2004 Sep; 22(27-28):3727-37. PubMed ID: 15315853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.